MINERVA SURGICAL, INC.

(UTRS)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
2.140 USD   -2.73%
08/12Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling
MT
08/10JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight
MT
08/10Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (UTRS) MINERVA SURGICAL Reports Q1 Revenue $10.9M, vs. Street Est of $10.8M

05/11/2022 | 04:04pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MINERVA S.A. 2.18% 14.07 Delayed Quote.32.74%
MINERVA SURGICAL, INC. -2.73% 2.14 Delayed Quote.-58.37%
All news about MINERVA SURGICAL, INC.
08/12Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling
MT
08/10JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight
MT
08/10Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overwei..
MT
08/09MINERVA SURGICAL : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/09MINERVA SURGICAL INC Management's Discussion and Analysis of Financial Condition and R..
AQ
08/09Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months E..
CI
08/09TRANSCRIPT : Minerva Surgical, Inc., Q2 2022 Earnings Call, Aug 09, 2022
CI
08/09MINERVA SURGICAL : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/09Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13M, vs. Street Est of $13.4M
MT
08/09Minerva Surgical Reports Second Quarter 2022 Financial Results
AQ
More news
Analyst Recommendations on MINERVA SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 51,1 M - -
Net income 2022 -32,6 M - -
Net Debt 2022 12,1 M - -
P/E ratio 2022 -1,88x
Yield 2022 -
Capitalization 61,8 M 61,8 M -
EV / Sales 2022 1,45x
EV / Sales 2023 1,88x
Nbr of Employees 157
Free-Float 92,6%
Chart MINERVA SURGICAL, INC.
Duration : Period :
Minerva Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MINERVA SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 2,14 $
Average target price 5,00 $
Spread / Average Target 134%
EPS Revisions
Managers and Directors
David M. Clapper President, Chief Executive Officer & Director
Joel R. Jung Chief Financial Officer
Ross A. Jaffe Chairman
Eugene V. Skalnyi Vice President-Medical Affairs
Dominique J. Filloux Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MINERVA SURGICAL, INC.-58.37%62
STRYKER CORPORATION-16.57%84 411
SMITH & NEPHEW PLC-18.52%11 104
INSPIRE MEDICAL SYSTEMS, INC.-4.39%6 300
AXONICS, INC.29.25%3 556
GLAUKOS CORPORATION13.37%2 397